Robert Spiera, MD

Hosptial for Special Surgery
New York, NY, United States

Dr. Spiera is the Director of the Vasculitis and Scleroderma Program at the Hospital for Special Surgery and a Professor of Clinical Medicine at Weill Cornell Medical College. He is the principal investigator in several clinical trials and observational studies focusing on scleroderma and vasculitis. Dr. Spiera specializes in the treatment of various rheumatologic conditions including scleroderma, vasculitis, systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, and many other conditions. He has authored over 150 publications relating to scleroderma, vasculitis, and other rheumatic diseases.

Disclosure information not submitted.

Presentation(s):

• 1543: Resolution of PMR Signs and Symptoms in Patients Treated with Sarilumab: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR) in Relapsing PMR

  Sunday, November 13, 2022
  9:30 AM – 9:35 AM Eastern Time

• 1543: Resolution of PMR Signs and Symptoms in Patients Treated with Sarilumab: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR) in Relapsing PMR

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)

  Monday, November 14, 2022
  11:45 AM – 11:55 AM Eastern Time